1. Rare and Complex Urology: Clinical Overview of ERN eUROGEN
- Author
-
Oomen, Loes, Leijte, Erik, Shilhan, Darren E., Battye, Michelle, Feitz, Wout F.J., Waltregny, David, Van der Aa, Frank, Spinoit, Anne-Françoise, Rösch, Wolfgang H., Schmiedeke, Eberhard, Fisch, Margit, Märzheuser, Stefanie, Gosemann, Jan-Hendrik, Hubertus, Jochen, Rawashdeh, Yazan, Thorup, Jorgen, Heloury, Yves, Leva, Ernesto, Mancini, Mariangela, Bagolan, Pietro, Sacco, Emilio, Verkauskas, Gilvydas, Feitz, Wout, Sloots, Cornelius, Czauderna, Piotr, Mauricio, Maria, Holmdahl, Gundela, Abrahamsson, Kate, Thomas, Kay, Cardozo, Linda, Chapple, Christopher, Sangar, Vijay, Greenwell, Tamsin, Watkin, Nick, Bujons Tur, Anna, Lozano Ortega, Jose, Pérez-Valderrama, Maria Begoña, Gutierrez Baños, Jose, Garcia Aparicio, Luis, Lopez, Manuel, Romero Otero, Javier, Lopez Pereira, Pedro, Herranz Amo, Felipe, Oswald, Josef, Abols, Valts, Frobe, Ana, Judit Molnar, Maria, Goergen, Martine, Dalmas, Miriam, Lovrecic, Luca, and ERN eUROGEN, [missing]
- Subjects
eUROGEN ,European level ,Health Personnel ,Urology ,education ,030232 urology & nephrology ,European Reference Network ,Disease ,HYPOSPADIAS ,Collaboration ,Complex conditions ,Rare ,Rare diseases ,03 medical and health sciences ,0302 clinical medicine ,Medicine and Health Sciences ,medicine ,Humans ,EPIDEMIOLOGY ,In patient ,Patient summary ,Retrospective Studies ,Data collection ,Settore MED/24 - UROLOGIA ,business.industry ,Retrospective cohort study ,medicine.disease ,Reconstructive and regenerative medicine Radboud Institute for Molecular Life Sciences [Radboudumc 10] ,Data extraction ,030220 oncology & carcinogenesis ,Medical emergency ,Diagnosis code ,business - Abstract
Background: In 2017, the European Commission launched 24 European Reference Networks (ERNs). ERN eUROGEN is the network for urorectogenital diseases and complex conditions, and started with 29 full member healthcare providers (HCPs) in 11 countries. It then covered 19 different disease areas distributed over three work -streams (WSs). Objective: To provide an overview and identify challenges in data collection at European level of the ERN eUROGEN patient population treated by HCPs in the network. Design, setting, and participants: A retrospective cohort study was conducted of the 29 HCPs who were full members between 2013 and 2019. Outcome measurements and statistical analysis: Data were extracted from the original HCP applications and the ERN continuous monitoring system. Patient volumes, new patient numbers, and procedures were compared between different WSs, countries, and HCPs. Discrepancies between monitoring and application data were identified. Results and limitations: Between 2013 and 2019, 122 040 patients required long-term care within the 29 HCPs. The volume of patients treated and procedures undertaken per year increased over time. Large discrepancies were found between patient numbers contained in the application forms and those reported in the continuous monitoring system (0-1357% deviation). Conclusions: Patient numbers and procedures increased across ERN eUROGEN HCPs. Reliable data extraction appeared challenging, illustrated by the patient volume dis-crepancies between application forms and the continuous monitoring data. Improved disease definitions, re-evaluation of affiliated HCPs, and valid data extraction are needed for future improvements. Patient summary: We analysed the patient population with rare urorectogenital dis-eases or complex conditions within the ERN eUROGEN network between 2013 and 2019. Clinical activity was found to increase, but differences in patient numbers were evident between healthcare providers. In order to acquire valid patient numbers, both improved definitions of diagnostic codes and greater insight into the data-gathering process are required. (c) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
- Published
- 2022